Skip to main content
37°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
99
100
Next >
Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug
January 06, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
NVO
TEVA
Rare Diagnosis Reveals Surprising Link Between Mysterious Symptoms
January 06, 2025
Via
Brandpoint
Topics
Product Recall
Exposures
Legal
Product Safety
Class Action Announcement for Applied Therapeutics, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Applied Therapeutics, Inc. - Contact Kessler Topaz Meltzer & Check, LLP
January 04, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Class Action Announcement for Applied Therapeutics, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Applied Therapeutics, Inc. - Contact Kessler Topaz Meltzer & Check, LLP
January 04, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Acquisition of Kadima Neuropsychiatry Institute for CNS & Psychedelic Research Planned; New Drug Application for Suicidal Depression Treatment: $NRXP
January 02, 2025
Via
PRLog
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
JPM
New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP
December 30, 2024
Via
PRLog
Exposures
Product Safety
Tickers
JPM
XRAY REMINDER: Kessler Topaz Meltzer & Check, LLP Urges XRAY Investors With Losses to Contact the Firm
January 04, 2025
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
XRAY
XRAY REMINDER: Kessler Topaz Meltzer & Check, LLP Urges XRAY Investors With Losses to Contact the Firm
January 04, 2025
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
XRAY
Texas-Based Artist Summer VonHolten Opens Up About Her Artistic Journey
January 04, 2025
Via
Zexprwire
Topics
Product Recall
Exposures
Legal
Product Safety
“The Tag Team Supreme” By Laura M. Quinn
January 03, 2025
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
First-Ever Autoimmune Diseases Registry Launches New Website Powered by the NIH’s All of Us Research Program
January 03, 2025
Via
AB Newswire
Exposures
Product Safety
China’s efforts in desertification control reflect harmonious coexistence between humanity and nature
January 03, 2025
Via
Prodigy
Topics
Climate Change
Energy
Product Recall
Exposures
Climate
Electricity Generation
Legal
Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth
January 03, 2025
Via
Benzinga
Topics
Supply Chain
Exposures
Product Safety
Supply Chain
Tickers
CTSO
Carmell, Mustang Bio, Revelation Biosciences Dominate Retail Biotech Talk As 2025 Kicks Off
January 03, 2025
Via
Stocktwits
Exposures
Product Safety
Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'
January 03, 2025
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
LLY
Tesla Recalls In 2024 Crossed 5 Million, But Most Were Fixed Via Software Updates: Majority Of Physical Recalls Were For This Vehicle
January 01, 2025
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
TSLA
Why Is Brain Cancer-Focused Kazia Therapeutics Stock Trading Lower On Tuesday?
December 31, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
KZIA
Why Is FTAI Aviation (FTAI) Stock Rocketing Higher Today
December 31, 2024
Via
StockStory
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
BA
FTAI
Why Is Cancer-Focused Verastem Oncology Stock Trading Higher On Tuesday?
December 31, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
VSTM
FDA And Nuwellis Address Potentially High-Risk Issue With Blood Circuit Device
December 31, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
NUWE
Axsome Reveals Data From Alzheimer's Studies, Analyst Sees Hope Despite Mixed Trial Results
December 31, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AXSM
ITCI
JNJ
OTSKF
Tesla Recalls Nearly 78,000 Model 3, Model Y Vehicles In China
December 31, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
TSLA
New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects Over 13 Million Americans Each Year: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
December 31, 2024
Via
Get News
Exposures
Product Safety
Tickers
NRXP
DENTSPLY SIRONA Inc. (XRAY) Investors: January 27, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
December 30, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
XRAY
Axsome Therapeutics Stock Tumbles As Alzheimer's Studies Reveal Mixed Results: Retail Sentiment Remains Bullish
December 30, 2024
Via
Stocktwits
Exposures
Product Safety
Applied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
December 30, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Class Action Announcement (APLT): A Securities Fraud Class Action Lawsuit Was Filed Against Applied Therapeutics, Inc.
December 28, 2024
Via
NewMediaWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
XRAY Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DENTSPLY SIRONA Inc. (XRAY)
December 28, 2024
Via
NewMediaWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
XRAY
Kaplan Fox Has Filed a Class Action to Recover Losses for Investors Who Purchased Common Stock of Applied Therapeutics, Inc. (NASDAQ: APLT)
December 27, 2024
Via
NewMediaWire
Exposures
Product Safety
Tickers
APLT
Bristol Myers Squibb Stock In Focus After FDA Approves Cancer Drug: Retail Sentiment Brightens
December 27, 2024
Via
Stocktwits
Exposures
Product Safety
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.